MyAverix Finance
HK · Healthcare
Guangzhou Baiyunshan Pharma (0874)
Medical Distribution
Guangzhou Baiyunshan Pharma (0874) is listed on HK in the Healthcare sector. Industry: Medical Distribution. As of 2026-05-21, reported market cap is $25.83B, P/E ratio is 7.60, net margin is 3.8%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 0874
Guangzhou Baiyunshan Pharma (0874) — FAQ
What is Guangzhou Baiyunshan Pharma's market cap?
Guangzhou Baiyunshan Pharma (0874) has a reported market cap of $25.83B (data as of 2026-05-21).
What is 0874's P/E ratio?
The price-to-earnings (P/E) ratio for Guangzhou Baiyunshan Pharma (0874) is 7.60 (data as of 2026-05-21).
Does Guangzhou Baiyunshan Pharma pay a dividend?
Dividend yield is not available in the current snapshot for Guangzhou Baiyunshan Pharma (0874). Check the MyAverix Finance app for the latest dividend data.
What sector is Guangzhou Baiyunshan Pharma in?
Guangzhou Baiyunshan Pharma (0874) is classified in the Healthcare sector (Medical Distribution industry).
What exchange is 0874 listed on?
0874 is listed on HK.
What is Guangzhou Baiyunshan Pharma's net margin?
Guangzhou Baiyunshan Pharma (0874) reports a net margin of 3.8% (data as of 2026-05-21).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.